XML 81 R62.htm IDEA: XBRL DOCUMENT v3.24.0.1
ACQUISITIONS AND OTHER ARRANGEMENTS - Transderm Scop Narrative (Details)
$ in Millions
12 Months Ended
Mar. 31, 2021
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Transderm Scop      
Asset Acquisition [Line Items]      
Purchase price $ 60    
Additional cash consideration 30    
Contingent Consideration 24    
Consideration transferred 84    
Series of Individually Immaterial Business Acquisitions      
Asset Acquisition [Line Items]      
Consideration transferred   $ 32 $ 21
Developed Product Rights | Transderm Scop      
Asset Acquisition [Line Items]      
Reacquired license rights fair value total $ 64    
Weighted-average useful life 9 years    
Developed Product Rights | Measurement Input Discount Rate | Transderm Scop      
Asset Acquisition [Line Items]      
Discount rate used to measure intangible assets 0.225    
Customer relationships | Transderm Scop      
Asset Acquisition [Line Items]      
Reacquired license rights fair value total $ 3    
Weighted-average useful life 7 years    
Customer relationships | Measurement Input Discount Rate | Transderm Scop      
Asset Acquisition [Line Items]      
Discount rate used to measure intangible assets 0.155